RBC Capital Keeps Their Buy Rating on Damora Therapeutics (DMRA)
at www.tipranks.com (Tue, 30-Jun 7:05 AM)
Damora Therapeutics Sets Sights on Clinical Milestones for Groundbreaking mutCALR Therapies in 2026
Market Chameleon (Wed, 13-May 8:46 AM)
